Albuquerque, NM — Februrary 12, 2013
The newest company in STC’s commercialization pipeline, Biophagy LLC, is gearing up for testing a new technology developed by Dr. Vojo Deretic, Chair of UNM’s Dept. of Molecular Genetics & Microbiology.

 

Albuquerque, NM – March 1, 2013
STC.UNM and Biophagy LLC, Albuquerque’s newest bioscience start-up, have signed an option to license agreement for technologies created at the University of New Mexico. The company will develop diagnostics and therapeutics for diseases related to autophagy.

 

Albuquerque, NM – March 1, 2013
Dr. Mary J. Ortner, PhD, MBA has been appointed president and CEO of Biophagy, LLC. Dr. Ortner has started or been involved in six entrepreneurial bioscience companies and worked at Boehringer Ingelheim Pharmaceuticals and Shire Biologics during her 25 year career in the pharmaceutical industry.

 

Albuquerque, NM – 2013
Dr. Steven Bradfute, PhD, has taken a position as scientific consultant with Biophagy, LLC. Dr. Bradfute works with Dr. Vojo Deretic at the University of New Mexico and will assist Biophagy with autophagy assay design and interpretation.

 

Albuquerque, NM – 2013
Biophagy, LLC has been awarded a grant from New Mexico Small Business Assistance to work with Sandia National Laboratories (Dr. Jeri Timlin and Dr. Bryan Carson) to develop spectroscopic assays for measuring autophagy and evaluating autophagy stimulating drugs.

 

Albuquerque, NM – August 14, 2013
Dr. Mary Ortner, PhD MBA, has been elected to the Board of Directors of the NM Biotechnology and Biomedical Association, (NMBio). With a twenty-year history serving bioscience in New Mexico, NM Bio is the BIO-affiliated NM trade association for bioscience. It provides monthly seminars for information exchange, develops initiatives for small business success, supports bioscience education/collaboration, and publicizes New Mexico’s bioscience industry. It serves as the voice of the state’s biotechnology/biomedical industry (http://nmbio.org/).

 

Albuquerque NM – January 2014
Dr. Mary J. Ortner, PhD, MBA, has been elected vice-president of the board of directors of NMBio, New Mexico’s BIO-affiliated trade association for bioscience industries.

 

Albuquerque, NM – 2014
Biophagy, LLC has been awarded a grant from New Mexico Small Business Assistance to work with Sandia National Laboratories (Dr. Jeri Timlin and Dr. Bryan Carson) to study binding sites and relative autophagy stimulating activity of several UNM compounds.

 

Albuquerque NM – January 2015
Dr. Mary J. Ortner, PhD, MBA, has been elected president of the board of NMBio, New Mexico’s BIO-affiliated trade association for bioscience industries.

 

Albuquerque, NM — January 2015
Biophagy has changed its corporate structure to an incorporated entity and will henceforth be known as Biophagy, Inc.

 

Albuquerque, NM – March 2016
Biophagy has been awarded a grant from the STC.NM Co-investment fund to continue its studies on selected university compounds as stimulants of autophagy.

 

Albuquerque, NM
Biophagy has been recognized for excellence in business accomplishments through the NM Small Business Assistance program.

 

Albuquerque, NM – 2016
Dr. Mary J. Ortner, PhD, MBA, Biophagy’s CEO has been given a Women of Influence—2016 award for recognition of her contribution to business and development in Albuquerque.

 

Mountainair, NM – June 2016
Biophagy announces that it moved its headquarters to Mountainair, NM at 1588 Deer Canyon Trail. It will continue to maintain an office at The BioScience Center, 1501Indian School Road, in Albuquerque.

 

Albuquerque, NM – November 2016
Biophagy has been awarded a Leverage Grant from New Mexico Small Business Assistance to work with Sandia National Laboratories (Jeri Timlin, PhD, and Bryan Carson, PhD). Biophagy will lead a consortium of three NM bioscience companies including Avisa Pharma (Santa Fe, NM), PureInfo Discovery (Albuquerque, NM) to investigate patented combinations of autophagy stimulants in the treatment of tuberculosis.

 

Albuquerque, NM – March 2017
Biophagy has been awarded a grant from the STC.NM Co-investment fund to study synergy in combining autophagy stimulants for the treatment of tuberculosis.

 

Albuquerque, NM – May 2017
Biophagy announces the addition of Ian Henderson, PhD, as its consultant in medicinal chemistry. Ian will be designing proprietary autophagy stimulants for its drug design program.

 

Albuquerque, NM – November 2017
Biophagy has been awarded a new Leverage Grant from New Mexico Small Business Assistance to work with Sandia National Laboratories (Dr. Jeri Timlin and Dr. Bryan Carson). Biophagy will lead a consortium of four NM bioscience companies, including Avisa Pharm a (Santa Fe, NM), Hyperimage Solutions (Rio Rancho, NM), and Omphalos Biosciences (Albuquerque, NM). The team will investigate proprietary autophagy stimulants and a new class of proprietary antibiotics for intracellular binding activities and in tuberculosis.